AMARIN CORP PLC\UK Capital Expenditures
AMARIN CORP PLC\UK (AMRN) reported Capital Expenditures of $252.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2021-04-29
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $1.00K, a 99.92% decline year-over-year.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $0.00.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for the quarter ending 2020-03-31 was $251.00K.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for fiscal 2020 was $252.00K, a 89.83% decline from fiscal 2019.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for fiscal 2019 was $2.48M, a 4172.41% increase from fiscal 2018.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for fiscal 2018 was $58.00K, a 383.33% increase from fiscal 2017.
- AMARIN CORP PLC\UK payments to acquire property, plant, and equipment for fiscal 2017 was $12.00K, a 42.86% decline from fiscal 2016.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.00K derived: sum of 3 quarters · filed 2021-02-25 | $252.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.00K derived: sum of 2 quarters · filed 2020-11-05 | $252.00K 10-Q · filed 2020-11-05 | $616.00K derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $251.00K 10-Q · filed 2020-08-04 | $615.00K derived: sum of 3 quarters · filed 2021-04-29 | $1.93M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-03-31 | $251.00K 10-Q · filed 2021-04-29 | $615.00K derived: sum of 2 quarters · filed 2021-04-29 | $1.93M derived: sum of 3 quarters · filed 2021-04-29 | |
| 2019-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.68M derived: sum of 2 quarters · filed 2021-02-25 | $2.48M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.11M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $801.00K 10-Q · filed 2020-08-04 | |||
| 2018-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $58.00K 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $53.00K 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $12.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $12.00K 10-Q · filed 2018-11-01 | $12.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $12.00K 10-Q · filed 2018-08-01 | $12.00K derived: sum of 3 quarters · filed 2019-02-27 | $12.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $12.00K 10-Q · filed 2018-05-02 | $12.00K derived: sum of 2 quarters · filed 2019-02-27 | $12.00K derived: sum of 3 quarters · filed 2019-02-27 | $12.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $0.00 derived: sum of 3 quarters · filed 2019-02-27 | $21.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $0.00 derived: sum of 2 quarters · filed 2017-11-01 | $21.00K 10-Q · filed 2017-11-01 | $39.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $21.00K 10-Q · filed 2017-08-02 | $39.00K derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $21.00K 10-Q · filed 2017-05-03 | $39.00K derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $28.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $10.00K 10-Q · filed 2016-11-03 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | $14.00K 10-K · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $14.00K 10-Q · filed 2014-11-06 | $86.00K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $14.00K 10-Q · filed 2014-08-07 | $86.00K derived: sum of 3 quarters · filed 2015-03-03 | $299.00K derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $14.00K 10-Q · filed 2014-05-09 | $86.00K derived: sum of 2 quarters · filed 2015-03-03 | $299.00K derived: sum of 3 quarters · filed 2015-03-03 | $471.00K derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $285.00K derived: sum of 2 quarters · filed 2015-03-03 | $457.00K derived: sum of 3 quarters · filed 2015-03-03 | $549.00K 10-K · filed 2015-03-03 |
| 2012-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $385.00K derived: sum of 2 quarters · filed 2013-11-07 | $477.00K 10-Q · filed 2013-11-07 | $842.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $264.00K 10-Q · filed 2013-08-08 | $629.00K derived: sum of 3 quarters · filed 2014-02-27 | $653.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $92.00K 10-Q · filed 2013-05-09 | $457.00K derived: sum of 2 quarters · filed 2014-02-27 | $481.00K derived: sum of 3 quarters · filed 2014-02-27 | |
| 2011-12-31 | $365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $389.00K derived: sum of 2 quarters · filed 2014-02-27 | $398.00K 10-K · filed 2014-02-27 | |
| 2011-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $33.00K 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $9.00K 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$1.00K derived: sum of 2 quarters · filed 2013-02-28 | $23.00K 10-K · filed 2013-02-28 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $24.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $24.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $116.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |